Format

Send to

Choose Destination
See comment in PubMed Commons below
J Gen Intern Med. 2013 Jul;28(7):886-93. doi: 10.1007/s11606-013-2379-3. Epub 2013 Mar 6.

Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use.

Author information

1
Department of Communication, Cornell University, 328 Kennedy Hall, Ithaca, NY, 14853, USA. jdn56@cornell.edu

Abstract

BACKGROUND:

While statin drugs are recommended for secondary prevention of coronary heart disease (CHD), there is no medical consensus on whether or not a statin should be added to lifestyle change efforts for primary prevention of CHD. Previous research suggests that exposure to direct-to-consumer advertising (DTCA) increases drug demand among those at comparatively low risk. Research has yet to examine whether individual-level DTCA exposure may influence statin use among men and women at high, moderate, or low risk for future cardiac events.

OBJECTIVE:

To determine the relationship between estimated exposure to DTCA for statin drugs and two clinical variables: diagnosis with high cholesterol and statin use.

DESIGN:

We used logistic regression to analyze repeated cross-sectional surveys of the United States population, merged with data on the frequency of DTCA appearances on national, cable, and local television, between 2001 and 2007.

PARTICIPANTS:

American adults (n=106,685) aged 18 and older.

MAIN MEASURES:

Levels of exposure to statin DTCA, based on ad appearances and TV viewing patterns; self-reports of whether or not a respondent has been diagnosed with high cholesterol, and whether or not a respondent took a statin in the past year.

KEY RESULTS:

Adjusting for potential confounders, we estimate that exposure to statin ads increased the odds of being diagnosed with high cholesterol by 16 to 20 %, and increased statin use by 16 to 22 %, among both men and women (p<0.05). These associations were driven almost exclusively by men and women at low risk for future cardiac events. There was also evidence of a negative association between DTCA exposure and statin use among high-risk women (p<0.05) CONCLUSIONS: This study provides new evidence that DTCA may promote over-diagnosis of high cholesterol and over-treatment for populations where risks of statin use may outweigh potential benefits.

PMID:
23463454
PMCID:
PMC3682042
DOI:
10.1007/s11606-013-2379-3
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center